CBD & Alzheimer’s

In October 2003, the federal government awarded the Department of Health and Human Services a patent titled “Cannabinoids as Antioxidants and Neuroprotectants,” which states: “Cannabinoids…are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”



Alzheimer’s disease; taking the edge off with cannabinoids?



The therapeutic potential of the endocannabinoid system for Alzheimer’s disease.



Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.



Cannabidiol: a promising drug for neurodegenerative disorders?



Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.



The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses.



The role of phytochemicals in the treatment and prevention of dementia.



Can Marijuana Prevent Alzheimer’s?



How Cannabinoids May Slow Brain Aging

Leave a Reply

Your email address will not be published. Required fields are marked *